Loading…
Based on limited metadata without access to the full warning letter text, Laboratorio Magnachem International, a pharmaceutical manufacturer, received an FDA warning on June 18, 2024, regarding drug products. The specific nature of the violations cannot be determined as the subject line information is unavailable. The warning falls under FDA drug product regulation, though the specific issuing office is not identified in the available metadata.